Currently, the only approved treatment for MASH on the market is the thyroid hormone receptor β agonist resmetirom (Rezdiffra ...

Any thoughts on milk thistle supplements in fatty liver disease that was diagnosed by an ultrasound due to elevated AST and ...

I’ve no history of nosebleeds, but over the past five weeks, I’ve had five. The first three times, the bleeding stopped after ...

New technology and drugs are transforming how doctors detect and treat silent liver disease MASLD before it leads to liver ...

A recommended 150 minutes per week at moderate intensity can help reduce liver inflammation and rid the organ of fat.

Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) has demonstrated sustained efficacy in a late-stage trial of patients with liver disease. The company presented positive two-year results from the open ...

Dr. Naim Alkhouri, Chief Academic Officer at Summit Clinical Research, emphasized, “Rezdiffra demonstrated broad, sustained efficacy across multiple noninvasive parameters at two years of ...

“Rezdiffra demonstrated broad, sustained efficacy across multiple noninvasive parameters at two years of treatment. A high, statistically significant percentage of patients with CSPH or probable ...

“Rezdiffra demonstrated broad, sustained efficacy across multiple noninvasive parameters at two years of treatment. A high, statistically significant percentage of patients with CSPH or probable CSPH ...